Subject: Re: Portfolio Exposure – Pharma Concentration Hi Elliot, Thank you for sharing your thoughts on this. We are aware of the current positioning and the broader sentiment around the sector, including the ongoing discussions regarding NHS funding and associated research allocations. Your note on the potential timing mismatch is noted, particularly in relation to how quickly expectations may already be reflected in market behaviour. At this stage, we are continuing to monitor developments closely and will take any necessary adjustments into consideration as more clarity emerges. Appreciate you flagging this. Best regards, Isabella Laurent Director of Risk Oversight. You read it twice, not for the words but for what sits behind them. Nothing careless. No opening offered. Just acknowledgement, measured and contained. She is paying attention. That much is clear, and this is the part that matters: one reply, poorly handled, and the whole thing collapses before it starts. You rest your fingers on the keyboard and don't type. There are four ways to go: - **Keep it short and professional**: acknowledge her position, press nothing, stay visible without standing out. Slow, but it breaks nothing. *Safe.* - **Ask about timelines**: how quickly adjustments usually get made, framed as curiosity. It might draw her out. *Controlled risk.* - **Offer analysis**: suggest what the firm should weigh if sentiment turns. Sounds confident, informed. Or exposed. - **Push for specifics**: decisions, positions, alignment: the information that would make everything easier, and the kind no one gives out freely. She hasn't made a mistake. If there's going to be one, it won't be hers. [[Push for specifics]] --- [[Cybercrime/The_Phisherman/Inquire about adjustments and timelines|Inquire about adjustments and timelines]] --- [[Cybercrime/The_Phisherman/Short and professional follow up|Keep it professional]] --- [[Suggest what the firm should do next|Suggest next steps]]